Astria Therapeutics Soars 16.91% on Market Ranking Improvement

Generado por agente de IAAinvest Movers Radar
jueves, 10 de abril de 2025, 5:21 am ET1 min de lectura

On April 10, 2025, Astria Therapeutics' stock surged by 16.91% in pre-market trading, marking a significant upturn after recent declines.

Astria Therapeutics has seen a notable improvement in its market ranking, scoring higher than 28% of companies evaluated by MarketBeat and ranking 767th out of 904 stocks in the medical sector. This positive shift in market perception could be a driving factor behind the recent stock price surge.

The consensus rating for

is a Strong Buy, with a price target of $26.29, indicating a potential upside of 484.22%. This optimistic outlook from analysts suggests that the company's future prospects are being viewed favorably, which could be contributing to the recent bullish sentiment.

author avatar
Ainvest Movers Radar

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios